Integrative clinical medicine最新文献_第5页

Identifying improvements in an emergency department elder friendly area based on patient experience “ED_EFA their voice project” 根据病人经验确定急诊科老年人友好区的改进" ED_EFA他们的声音项目"

Integrative clinical medicine Pub Date : 2019-01-01 DOI: 10.15761/ICM.1000150

M. Puig, Miriam Mateo, M. Blázquez, J. Ris

引用次数: 0

Education and informed decision making for prostate cancer screening in a high risk African American community 非裔美国人高风险社区前列腺癌筛查的教育和知情决策

Integrative clinical medicine Pub Date : 2019-01-01 DOI: 10.15761/icm.1000146

P. Dhillon, P. Grivas, B. Hobbs, Daniel S Carlson, S. Abraksia

引用次数: 1

Application of silver needle thermal therapy in the chronic pain 银针热疗在慢性疼痛中的应用

Integrative clinical medicine Pub Date : 2019-01-01 DOI: 10.15761/ICM.1000138

Junmin Yu, Chuansheng Liu, Yanwei Yin, Fenghe Xu, Yusheng Yi, Chao Meng

引用次数: 0

Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients. 外周犬尿氨酸-3-单加氧酶缺乏是精神分裂症患者代谢综合征的潜在危险因素。

Integrative clinical medicine Pub Date : 2017-01-01 Epub Date: 2017-05-10 DOI: 10.15761/ICM.1000105

Gregory Oxenkrug, Marieke van der Hart, Julien Roeser, Paul Summergrad

{"title":"Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients.","authors":"Gregory Oxenkrug, Marieke van der Hart, Julien Roeser, Paul Summergrad","doi":"10.15761/ICM.1000105","DOIUrl":"https://doi.org/10.15761/ICM.1000105","url":null,"abstract":"<p><p>Increased predisposition of schizophrenia patients (SP) to development of obesity and insulin resistance suggested common signaling pathway between metabolic syndrome (MetS) and schizophrenia. Deficiency of kynurenine-3-monooxygenase (KMO), enzyme catalyzing formation of 3-hydroxykynurenine (3-HK) from kynurenine (Kyn), a tryptophan (Trp) metabolite, might contribute to development of MetS as suggested by non-expression of KMO genes in human fat tissue and elevated serum concentrations of Kyn and its metabolites, kynurenic (KYNA) and anthranilic (ANA) acids, in diabetic patients and Zucker fatty rats (ZFR). Markers of KMO deficiency: decreased 3-HK and elevated Kyn, KYNA and ANA, were observed in brains and spinal fluids of SP, and in brains and serum of experimental animals with genetically- or pharmacologically-induced KMO deficiency. However, elevated concentrations of ANA and decreased 3-HK were reported in serum of SP without concurrent increase of Kyn and KYNA. Present study aimed to re-assess serum Kyn metabolites (HPLC-MS) in a sub-group of SP with elevated KYNA. We found increased Kyn concentrations (by 30%) and Kyn:Trp ratio (by 20%) in serum of SP with elevated KYNA concentrations (by 40%). Obtained results and our previous data suggest that peripheral KMO deficiency might be manifested by, at least, two different patterns: elevated ANA with decreased 3-HK; and elevated KYNA and KYN. The latter pattern was previously described in type 2 diabetes patients and might underline increased predisposition of SP to development of MetS. Assessment of peripheral KMO deficiency might identify SP predisposed to MetS. Attenuation of the consequences of peripheral KMO deficiency might be a new target for prevention/treatment of obesity and diabetes in SP.</p>","PeriodicalId":91880,"journal":{"name":"Integrative clinical medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35202300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 22